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ABSTRACT
Objective: To show the effectiveness of various potent topical steroids in treating severe oral ulcerations without
any side-effects. Potent topical steroids are recommended as an alternative treatment for severe oral ulcerations
in Herpes associated erythema multiforme (HAEM) patients. Case report: A 50-year-old female presented at
the Oral Medicine clinic at the Faculty of Dentistry, Chulalongkorn University, Bangkok with a chief complaint
of severe pain in her oral cavity and lips for 1 week. She had no systemic diseases, except for vertigo, and was
currently taking cetirizine hydrochloride. An oral examination revealed a hemorrhagic crust on her lips, scaly,
large ulcerations on the upper labial mucosa, and multiple oral ulcerations on the right and left buccal mucosa. She
had limited mouth opening and difficult in eating. She was treated with benzydamine hydrochloride mouthwash,
triamcinolone acetonide 0.1% mouthwash, and fluocinolone acetonide 0.1% solution. The patient’s pain and severe
oral lesions gradually reduced after treatment for one week. At the one month follow-up, all lesions had completely
disappeared and the laboratory investigation report showed that she was Herpes simplex virus Ab IgG type I and
Type II positive; therefore, the diagnosis in this case was HAEM.
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INTRODUCTION
1-α), IL-6, and IL-8, in whole unstimulated saliva in
subjects with erosive OLP.8

Steroids have been widely used either systemically or
topically to treat various oral mucosal diseases such
as oral lichen planus (OLP),1, 2 oral ulceration,3 oral
lichenoid lesion,4 mucous membrane pemphigoid,5
pemphigus,6 and erythema multiforme (EM).7 Steroids
inhibit the expression of prostaglandins and many
proinflammatory cytokines, thus steroids reduce pain
and inflammation. Moreover, steroids have an indirect
effect on T helper cells and a direct effect on B cells,
therefore antibody production is reduced. Moreover,
glucocorticoids act on immune cells both directly and
indirectly to suppress the induction of pro-inflammatory
responses. Steroids upregulate the expression of antiinf lammatory proteins, while downregulating the
expression of proinflammatory proteins (Figure 1).
Interestingly, the therapeutic use of the topical steroid
dexamethasone resulted in significantly decreased
saliva levels of proinflammatory cytokines, such as
tumor necrosis factor-alpha, interleukin-1-alpha (IL-

Various methods are used to treat severe oral lesions
either systemically or topically. Many forms of steroids
are available for treating oral mucosal diseases, such as
oral, injection, topical, inhalation, and mouthwashes.
Topical steroids are an alternative method of drug
delivery that are more targeted to the lesions compared
with injection or systemic steroids. Because the
oral mucosa is highly vascularized, drugs absorbed
through the oral mucosa directly enter the systemic
circulation.9, 10 However the absorption is much lower
compared with systemic treatment, resulting in fewer
systemic side-effects.11 Using topical steroids to treat
oral mucosal diseases is effective because they can
penetrate directly into the oral lesions with minimal
side-effects compared with systemic steroids.
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Figure 1. Glucocorticoids act on immune cells both directly and indirectly to suppress the induction of pro-inflammatory
responses. (Modified from Nature Publishing Group Nature Reviews/ Immunology, 2006)
Table 1. Various topical steroids’ potency, class, and formulation*
Potency

Class

Topical corticosteroid

Formulation

Ultra high

I

Clobetasol propionate

Cream, 0.05%

High

II

Betamethasone dipropionate
Fluocinonide

Ointment, 0.05%
Cream, ointment or gel, 0.05%

III

Betamethasone dipropionate
Betametasone valerate
Fluocinolone acetonide
Triamcinolone acetonide

Cream, 0.05%
Ointment, 0.1%
Orabase, 0.1%
Ointment, 0.1%

IV

Fluocinolone acetonide
Triamcinolone acetonide

Ointment, 0.025%
Cream, 0.1%

V

Betamethasone valerate
Fluocinolone acetonide
Triamcinolone acetonide

Cream, 0.1%
Cream, 0.025%
Lotion, 0.1%

VI

Betamethasone valerate
Fluocinolone acetonide

Lotion, 0.05%
Solution, 0.01%

VII

Dexamethasone sodium phosphate
Hydrocortisone acetate

Cream, 0.1%
Cream, 1%

Moderate

Low

*Modified from Essential Medicines and Health Products Information Portal A World Health Organization resource. WHO
Model Prescribing Information: Drugs Used in Skin Diseases, 1997.

Many topical steroids are now available in different
preparations. The classification of a topical steroid based
on potency may vary depending on the formulation
and concentration.12 In general, ointments are more
potent compared with creams or lotions. Fluocinolone
acetonide 0.1% in orabase (FAO) and triamcinolone
acetonide (TA) 0.1% ointment are high potency topical

steroids. In contrast, fluocinolone acetonide 0.01% in
solution (FAS) and dexamethasone sodium phosphate
0.1% cream are low potency steroids, whereas
clobetasol propionate 0.05% cream is the highest
potency topical steroid. Therefore, the same topical
steroid in a different formulation or concentration will
have different potencies (Table 1).
115

Journal of Dentistry Indonesia 2019, Vol. 26, No. 2, 114-118
steroids for one week. Her pain was also reduced when
using benzydamine hydrochloride and topical steroids
for 1 week. At the one-month follow-up, all lesions had
completely disappeared (Figure 3 A, B, C, D) and the
laboratory investigation report showed that she was
Herpes simplex virus (HSV) Ab IgG type I and Type
II positive; therefore, the diagnosis in this case was
Herpes associated erythema multiforme (HAEM). No
side effects from the topical steroid treatments were
observed in this case.

Figure 2. Hemorrhagic crust and scaly lips (A, B) with large
ulceration on the upper labial mucosa (C), and limited mouth
opening (D).

DISCUSSION
Er y t hema mult ifor me ( EM ) is a self-li m ited
hypersensitivity reaction involving the skin and mucous
membranes. Herpes simplex virus is the most common
condition associated with recurrent EM; however, in
most cases a cause cannot be identified. More than
half of the patients did not have an identifiable cause
for recurrent EM, and the frequency of a diagnosis of
HSV associated with HAEM varies between studies.13,
14
When target lesions are not present, the diagnosis
of EM is very difficult. For more severe cases of
EM, supportive care and treatment with systemic
steroids or other immunosuppressive agents are
necessary. Furthermore, in recurrent EM cases, chronic
suppressive antiviral therapy may be indicated. 15
When there is mucosal involvement of HSV or
EM, severe symptoms, or a high rate of recurrence,
treatment and prophylaxis with antiviral agents may
be considered. Oral acyclovir has shown to be effective
for prophylaxis, with valacyclovir and famciclovir
providing alternate treatment options.16

Figure 3. One month after treatment with benzydamine
hydrochloride mouthwash, TA 0.1% mouthwash, and FAS
0.1% solution, all mucosa appeared normal (A, B, C, D).

In this report, we present the case of a 50-year-old
female with severe oral ulceration of Herpes associated
erythema multiforme (HAEM) that demonstrated that
potent topical steroids can be effectively used to treat
these severe oral lesions without side-effects.

In the present case, the lesions presented in the oral
cavity and lips, however, there were no skin lesions
or target lesions. The oral manifestation of severe
generalized ulceration and hemorrhagic crusts on the
lips are pathognomonic signs of EM. Moreover, positive
laboratory results for HSV Ab IgG type I and Type II
can confirm the diagnosis of HAEM. Potent topical
steroids in various forms, such as TA 0.1% mouthwash
and FAS 0.1%, were effective in the treatment of the
severe oral lesions in this case.

CASE REPORT
A 50-year-old female came to the Oral Medicine clinic
at the Faculty of Dentistry, Chulalongkorn University,
Bangkok in August, 2017 with a chief complaint of
severe pain in her oral cavity and lips for 1 week.
She had no serious systemic diseases except vertigo
and was currently taking cetirizine (Zyrtec). An oral
examination revealed a hemorrhagic crust on her lips,
scaly, large ulcerations on the upper labial mucosa,
and multiple oral ulcerations on the right and left
buccal mucosa (Fig. 2 A, B, C, D). She had limited
mouth opening. She was treated with benzydamine
hydrochloride mouthwash and TA 0.1% mouthwash
three times a day. FAS 0.1% solution was applied on
her lips three times a day. The lesions in her oral cavity
and lips gradually improved after treatment with topical

In summary, the advantages of topical steroids are that
they rapidly reduce pain and inflammation. Topical
steroids were successfully used in this case and the
oral lesions showed complete resolution without
any side-effects during the 1 month of treatment. A
previous report demonstrated that the topical steroids
FAS or FAO 0.1% were safe and effective in treating
HAEM in a pregnant patient.7 Therefore, treating
severe oral lesions with short-term potent topical
steroids is recommended because they have been
found to be effective, safe, and without side-effects.
Interestingly, one rare case of Plasma cell mucositis
showed no response to any medications, in contrast,
116
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It is important to differential diagnosis between
primary herpes simplex infection from HAEM,
particulary in children. When HAEM occurs in
children, the treatment plan will be supportive care
and pain control. Non steroidal anti-inflammatory drug
(NSAIDs) may be used for more immediate pain relief.
If the patients have difficulty eating and drinking, a
topical anesthetic mouthwash may be administered
before meals for treating oral lesions. Recent report
showed that the topical prophylactic treatment in
HAEM patient with acyclovir does not seem to prevent
further episodes of erythema multiforme.19 Because
of its similar symptoms, it is difficult to differential
diagnosis of herpes simplex infection from HAEM in
its early stage.
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